Recurrent Glioblastoma

Could there be a gleevec for brain cancer?

The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, but also for the story behinds its development. The ...

Feb 09, 2015
popularity 3.5 / 5 (2) | comments 0

Novel cancer vaccine approach for brain tumors

Glioblastoma is the most common aggressive primary brain tumor, and despite advances in standard treatment, the median survival is about 15 months (compared to 4 months without treatment). Researchers at Thomas Jefferson ...

Nov 13, 2014
popularity 5 / 5 (2) | comments 0

Latest Spotlight News

People use handshakes to sniff each other out

Limp or firm, your handshake conveys subliminal social cues. Now, research reveals it also transmits chemical signals that could explain why the greeting evolved in the first place.